1-3 of 3
Jonas Jutzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Shorespan-017: Phase 3 extension study for safety of bomedemstat in participants with essential thrombocythemia who received bomedemstat from a prior clinical study

Free
David Ross, Andrew Wilson, Tara Cochrane, William Stevenson, James Liang, Marco Brociner, Francesca Palandri, Stephen Larsen, Merit Hanna, Alessandro Maria Vannucchi, Kristen Pettit, Natalia Curto-Garcia, Harinder Gill, Uche Okoro, Jonas Jutzi, Patricia Marinello, Monia Marchetti
Journal: Blood
Blood (2025) 146 (Supplement 1): 2033.
https://doi.org/10.1182/blood-2025-2033
Published: 2025
Journal Articles

Efficacy and safety of the LSD1 inhibitor bomedemstat in participants with polycythemia vera (PV) resistant or intolerant to cytoreductive therapy: The Phase 2 shorespan-004 study

Free
Lindsay Rein, Alice Livings, Rebecca Frewin, Andrew Innes, Ali Mahdi, Ciro Rinaldi, Natalia Curto-Garcia, Jennifer Vaughn, Joseph Shatzel, Paul Yeh, Jessica Flynn, Jonas Jutzi, Patricia Marinello, Michael Leahy
Journal: Blood
Blood (2025) 146 (Supplement 1): 83.
https://doi.org/10.1182/blood-2025-83
Published: 2025
Journal Articles

Mutation-Specific Differences in the Relationship between Obesity and Clonal Hematopoiesis, with a Focus on JAK2 V617F and MPN Prevention

Free
Benjamin Rolles, Aswin Sekar, Laura Serrano-Ron, Noorul Mifra Ameerul Faiz, Andrea Perry, Addison Clare Hillerbrandt, Jessica Hem, Jonas Jutzi, Anna E. Marneth, Abhishek Niroula, Alexander G. Bick, Christopher J. Gibson, Gabriel K. Griffin, Md Mesbah Uddin, Pradeep Natarajan, Benjamin Levine Ebert, Peter van Galen, Fatima Al-Shahrour, Sahand Hormoz, Ann Mullally
Journal: Blood
Blood (2024) 144 (Supplement 1): 872.
https://doi.org/10.1182/blood-2024-204211
Published: 2024